Prelude Therapeutics Incorporated Common Stock (PRLD)
Stock · NASDAQ · Health Care
$5.47as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$4.05
Industry
Biotechnology: Pharmaceutical Preparations
Fundamentals
- Market cap
- $372.74M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- —
- Dividend yield
- —
- Beta
- —
- Avg. volume
- —
How Prelude Therapeutics Incorporated Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 10, 2026 · via SEC EDGAR / Finnhub
Prelude Therapeutics Incorporated Common Stock Competitors
Chosen by industry and closest market cap.
- PRLDPrelude Therapeutics Incorporated Common Stock$5.47▼ 13.72%Market cap $372.74MP/E —
- UPBUpstream Bio Inc. Common Stock$6.68▼ 1.62%Market cap $373.87MP/E —$5.85$33.68
- DMACDiaMedica Therapeutics Inc. Common Stock$6.39▼ 5.33%Market cap $364.79MP/E —$5.14$10.42
- RCKTRocket Pharmaceuticals Inc. Common Stock$3.86▲ 6.49%Market cap $386.55MP/E —$2.53$5.45
- ENTAEnanta Pharmaceuticals Inc. Common Stock$13.6▼ 1.45%Market cap $387.91MP/E —$7.05$17.15
- ZNTLZentalis Pharmaceuticals Inc. Common Stock$3.8▼ 2.06%Market cap $355.93MP/E —$1.21$6.95
- CATXPerspective Therapeutics Inc. Common Stock$3.1▼ 2.67%Market cap $338.72MP/E —$1.96$6.16
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| PRLD Prelude Therapeutics Incorporated Common Stock | $372.74M | — | $5.47 | ▼ 13.72% | |
| UPB Upstream Bio Inc. Common Stock | $373.87M | — | $6.68 | ▼ 1.62% | $5.85$33.68 |
| DMAC DiaMedica Therapeutics Inc. Common Stock | $364.79M | — | $6.39 | ▼ 5.33% | $5.14$10.42 |
| RCKT Rocket Pharmaceuticals Inc. Common Stock | $386.55M | — | $3.86 | ▲ 6.49% | $2.53$5.45 |
| ENTA Enanta Pharmaceuticals Inc. Common Stock | $387.91M | — | $13.6 | ▼ 1.45% | $7.05$17.15 |
| ZNTL Zentalis Pharmaceuticals Inc. Common Stock | $355.93M | — | $3.8 | ▼ 2.06% | $1.21$6.95 |
| CATX Perspective Therapeutics Inc. Common Stock | $338.72M | — | $3.1 | ▼ 2.67% | $1.96$6.16 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga · 8/20/2026
- Prelude Therapeutics Q2 EPS $(0.14) Beats $(0.20) Estimate, Sales $5.704Mbenzinga · 8/11/2026
- Prelude Therapeutics Q2 EPS $(0.14) Beats $(0.20) Estimate, Sales $5.704MBenzinga · 8/11/2026
Insider Activity
Insider Actions →Acquired
8.56M
Disposed
1.41M
- Victor Sandor · June 9, 2026 · Grant38.0K
- Dorton Katina · June 9, 2026 · Grant38.0K
- David P. Bonita · June 9, 2026 · Grant38.0K
- Babler Martin · June 9, 2026 · Grant38.0K
- Paul A. Friedman · June 9, 2026 · Grant38.0K
- BAKER JULIAN · June 9, 2026 · Grant38.0K
- Morris Charles Q · May 1, 2026 · Grant450.0K @ $4.7
- RA Capital Healthcare Fund LP · April 27, 2026 · J1.41M
- David P. Bonita · April 21, 2026 · Buy1.13M @ $4.44
- David P. Bonita · April 21, 2026 · Buy1.69M @ $4.44
- ORBIMED ADVISORS LLC · April 21, 2026 · Buy1.13M @ $4.44
- ORBIMED ADVISORS LLC · April 21, 2026 · Buy1.69M @ $4.44
- BAKER JULIAN · April 21, 2026 · Buy2.14M @ $4.44
- BAKER JULIAN · April 21, 2026 · Buy114.6K @ $4.44
Institutional Ownership
March 31, 2026
- Total shares held
- 30.63M
- Total value held
- $102.81M
- Institutional holders
- 52
Top holders this quarter
- Unknown10.91M
- Unknown10.12M
- Unknown1.59M
- Unknown1.23M
- Unknown947.0K
- Unknown923.6K
- Unknown558.3K
- Unknown511.5K
- Unknown382.7K
- Unknown358.9K
See the full, filterable feed with live charts on the MarketWall dashboard.